Gut microbiota: Implications in Parkinson's disease

Arun Parashar1, Malairaman Udayabanu1

  • 1Jaypee University of Information Technology, Waknaghat, District- Solan, Himachal Pradesh, PIN-173234, India.

Insights

The gut microbiome influences brain function and neurological conditions. This review explores the link between gut microbiota and Parkinson's disease pathology, examining if dysbiosis is a cause or effect.

Area of Science:

  • Neuroscience
  • Microbiology
  • Gastroenterology

Background:

  • Gut microbiota (GM) impacts neurological functions including cognition, learning, and memory.
  • GM modulation affects brain development and behavior, and is linked to neurological disorders like Alzheimer's disease and Parkinson's disease (PD).
  • PD patients exhibit GM dysbiosis, but its causal role remains unclear.

Purpose of the Study:

  • To review and synthesize evidence connecting gut microbiota and Parkinson's disease pathology.
  • To explore the potential causal relationship between GM dysbiosis and PD development.
  • To consolidate direct and indirect evidence linking GM to PD.

Main Methods:

  • Literature review of studies on gut microbiota and neurological disorders.
  • Analysis of research investigating GM dysbiosis in Parkinson's disease.
  • Synthesis of evidence on the gut-brain axis in neurodegenerative diseases.

Main Results:

  • The gut microbiome plays a significant role in brain health and disease.
  • Evidence suggests a strong association between gut dysbiosis and Parkinson's disease.
  • The review highlights potential mechanisms linking gut health to PD pathology.

Conclusions:

  • Gut microbiota alterations are implicated in Parkinson's disease.
  • Further research is needed to determine if gut dysbiosis is a cause or consequence of PD.
  • Understanding the gut-brain axis is crucial for novel PD therapeutic strategies.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.9K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K